• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Stroke metrics during the first year of the COVID-19 pandemic, a tale of two comprehensive stroke centers

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Oct 11;13(1):17171.
doi: 10.1038/s41598-023-44277-2. Stroke metrics during the first year of the COVID-19 pandemic, a tale of two comprehensive stroke centers

Lara Carvalho de Oliveira[SUP] #[/SUP][SUP] 1 [/SUP], Ana Ponciano[SUP] #[/SUP][SUP] 2 [/SUP], Nima Kashani[SUP] #[/SUP][SUP] 3 [/SUP], Suzete N F Guarda[SUP] 2 [/SUP], Michael D Hill[SUP] 4 [/SUP], Eric E Smith[SUP] 4 [/SUP], Jillian M Stang[SUP] 4 [/SUP], Anand Viswanathan[SUP] 2 [/SUP], Ashby C Turner[SUP] 2 [/SUP], Aravind Ganesh[SUP] 4 [/SUP]



Affiliations
Abstract

Although a decrease in stroke admissions during the SARS-CoV-2 pandemic has been observed, detailed analyses of the evolution of stroke metrics during the pandemic are lacking. We analyzed changes in stroke presentation, in-hospital systems-of-care, and treatment time metrics at two representative Comprehensive Stroke Centers (CSCs) during the first year of Coronavirus disease 2019 pandemic. From January 2018 to May 2021, data from stroke presentations to two CSCs were obtained. The study duration was split into: period 0 (prepandemic), period 1 (Wave 1), period 2 (Lull), and period 3 (Wave 2). Acute stroke therapies rates and workflow times were compared among pandemic and prepandemic periods. Analyses were adjusted for age, sex, comorbidities, and pre-morbid care needs. There was a significant decrease in monthly hospital presentations of stroke during Wave 1. Both centers reported declines in reperfusion therapies during Wave 1, slowly catching up but never to pre pandemic numbers, and dropping again in Wave 2. Both CSCs experienced in-hospital workflow delays during Waves 1 and 2, and even during the Lull period. Our results highlight the need for proactive strategies to reduce barriers to workflow and hospital avoidance for stroke patients during crisis periods.


 
Back
Top Bottom